Testing effectiveness (Phase 2)Study completedNCT00511303
What this trial is testing
Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia
Who this might be right for
Chronic Myeloid Leukemia
University of Bologna 200